RPHM - Reneo Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Reneo Pharmaceuticals's activity chart (see below) currently has 15 price targets and 17 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 78.94% with an average time for these price targets to be met of 132.82 days.

Most recent stock forecast was given by MITCHELL KAPOOR from HC WAINWRIGHT on 14-May-2024. First documented stock forecast 04-May-2021.

Best performing analysts who are covering RPHM - Reneo Pharmaceuticals:

Mitchell Kapoor Yasmeen Rahimi Gobind Singh Joseph Schwartz Brian Skorney Eun Yang

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 14-May-2024

$30

2 years 5 months 17 days ago
(14-May-2024)

3/5 (60%)

$15.8 (111.27%)

64

Buy Since 24-Mar-2022

$10

$8.18 (449.45%)

$15

2 years 10 months 16 days ago
(15-Dec-2023)

2/2 (100%)

$-4.2 (-29.58%)

460

Hold Since 15-Dec-2023

$18

$16.18 (889.01%)

$240

2 years 10 months 16 days ago
(15-Dec-2023)

1/2 (50%)

$3.8 (26.76%)

145

Buy Since 04-May-2021

$4

$2.18 (119.78%)

$25

2 years 10 months 17 days ago
(14-Dec-2023)

5/6 (83.33%)

$-9.4 (-70.15%)

163

Buy Since 19-Sep-2022

$30

$28.18 (1548.35%)

$30

3 years 1 months 23 days ago
(08-Sep-2023)

3/3 (100%)

$-41.1 (-57.81%)

71

Show more analysts

Please expand the browser size to see the chart

What is RPHM (Reneo Pharmaceuticals) average time for price targets to be met?

On average it took 133 days for the stock forecasts to be reached, with an average price target met ratio of 78.94%.

Which analyst most recently updated their price target on RPHM (Reneo Pharmaceuticals)?

Mitchell Kapoor

Which analyst has the most public recommendations on RPHM (Reneo Pharmaceuticals)?

Mitchell Kapoor has 9 price targets and 7 ratings on RPHM

Which analyst is the currently most bullish on RPHM (Reneo Pharmaceuticals)?

Brian Skorney with the highest potential upside of $278.18

Which analyst is the currently most reserved on RPHM (Reneo Pharmaceuticals)?

Mitchell Kapoor with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?